The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prescription & Rx Sunglass Market Research Report 2024
Synopsis
The global Prescription & Rx Sunglass market was valued at US$ 2602.6 million in 2023 and is anticipated to reach US$ 3116.2 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
North American market for Prescription & Rx Sunglass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prescription & Rx Sunglass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prescription & Rx Sunglass include Luxottica (Italy), Safilo (France), Charmant (US), Marchon (US), Fielmann (Germany), De Rigo (Italy), Bausch & Lomb (US), Carl Zeiss (Germany) and Essilor (France), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prescription & Rx Sunglass, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription & Rx Sunglass.
Report Scope
The Prescription & Rx Sunglass market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prescription & Rx Sunglass market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription & Rx Sunglass manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luxottica (Italy)
Safilo (France)
Charmant (US)
Marchon (US)
Fielmann (Germany)
De Rigo (Italy)
Bausch & Lomb (US)
Carl Zeiss (Germany)
Essilor (France)
Rodenstock (Germany)
Hoya Corporation (Japan)
Segment by Type
Glass
CR-39
Polycarbonate
Polyurethane
Segment by Application
Hazardous Environments
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prescription & Rx Sunglass manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prescription & Rx Sunglass in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Prescription & Rx Sunglass market was valued at US$ 2602.6 million in 2023 and is anticipated to reach US$ 3116.2 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
North American market for Prescription & Rx Sunglass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prescription & Rx Sunglass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prescription & Rx Sunglass include Luxottica (Italy), Safilo (France), Charmant (US), Marchon (US), Fielmann (Germany), De Rigo (Italy), Bausch & Lomb (US), Carl Zeiss (Germany) and Essilor (France), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prescription & Rx Sunglass, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription & Rx Sunglass.
Report Scope
The Prescription & Rx Sunglass market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prescription & Rx Sunglass market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription & Rx Sunglass manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luxottica (Italy)
Safilo (France)
Charmant (US)
Marchon (US)
Fielmann (Germany)
De Rigo (Italy)
Bausch & Lomb (US)
Carl Zeiss (Germany)
Essilor (France)
Rodenstock (Germany)
Hoya Corporation (Japan)
Segment by Type
Glass
CR-39
Polycarbonate
Polyurethane
Segment by Application
Hazardous Environments
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prescription & Rx Sunglass manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prescription & Rx Sunglass in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prescription & Rx Sunglass Market Overview
1.1 Product Overview and Scope of Prescription & Rx Sunglass
1.2 Prescription & Rx Sunglass Segment by Type
1.2.1 Global Prescription & Rx Sunglass Market Value Comparison by Type (2024-2030)
1.2.2 Glass
1.2.3 CR-39
1.2.4 Polycarbonate
1.2.5 Polyurethane
1.3 Prescription & Rx Sunglass Segment by Application
1.3.1 Global Prescription & Rx Sunglass Market Value by Application: (2024-2030)
1.3.2 Hazardous Environments
1.3.3 Others
1.4 Global Prescription & Rx Sunglass Market Size Estimates and Forecasts
1.4.1 Global Prescription & Rx Sunglass Revenue 2019-2030
1.4.2 Global Prescription & Rx Sunglass Sales 2019-2030
1.4.3 Global Prescription & Rx Sunglass Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prescription & Rx Sunglass Market Competition by Manufacturers
2.1 Global Prescription & Rx Sunglass Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prescription & Rx Sunglass Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prescription & Rx Sunglass Average Price by Manufacturers (2019-2024)
2.4 Global Prescription & Rx Sunglass Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prescription & Rx Sunglass, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prescription & Rx Sunglass, Product Type & Application
2.7 Prescription & Rx Sunglass Market Competitive Situation and Trends
2.7.1 Prescription & Rx Sunglass Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prescription & Rx Sunglass Players Market Share by Revenue
2.7.3 Global Prescription & Rx Sunglass Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prescription & Rx Sunglass Retrospective Market Scenario by Region
3.1 Global Prescription & Rx Sunglass Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prescription & Rx Sunglass Global Prescription & Rx Sunglass Sales by Region: 2019-2030
3.2.1 Global Prescription & Rx Sunglass Sales by Region: 2019-2024
3.2.2 Global Prescription & Rx Sunglass Sales by Region: 2025-2030
3.3 Global Prescription & Rx Sunglass Global Prescription & Rx Sunglass Revenue by Region: 2019-2030
3.3.1 Global Prescription & Rx Sunglass Revenue by Region: 2019-2024
3.3.2 Global Prescription & Rx Sunglass Revenue by Region: 2025-2030
3.4 North America Prescription & Rx Sunglass Market Facts & Figures by Country
3.4.1 North America Prescription & Rx Sunglass Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prescription & Rx Sunglass Sales by Country (2019-2030)
3.4.3 North America Prescription & Rx Sunglass Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prescription & Rx Sunglass Market Facts & Figures by Country
3.5.1 Europe Prescription & Rx Sunglass Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prescription & Rx Sunglass Sales by Country (2019-2030)
3.5.3 Europe Prescription & Rx Sunglass Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prescription & Rx Sunglass Market Facts & Figures by Country
3.6.1 Asia Pacific Prescription & Rx Sunglass Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prescription & Rx Sunglass Sales by Country (2019-2030)
3.6.3 Asia Pacific Prescription & Rx Sunglass Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prescription & Rx Sunglass Market Facts & Figures by Country
3.7.1 Latin America Prescription & Rx Sunglass Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prescription & Rx Sunglass Sales by Country (2019-2030)
3.7.3 Latin America Prescription & Rx Sunglass Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prescription & Rx Sunglass Market Facts & Figures by Country
3.8.1 Middle East and Africa Prescription & Rx Sunglass Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prescription & Rx Sunglass Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prescription & Rx Sunglass Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prescription & Rx Sunglass Sales by Type (2019-2030)
4.1.1 Global Prescription & Rx Sunglass Sales by Type (2019-2024)
4.1.2 Global Prescription & Rx Sunglass Sales by Type (2025-2030)
4.1.3 Global Prescription & Rx Sunglass Sales Market Share by Type (2019-2030)
4.2 Global Prescription & Rx Sunglass Revenue by Type (2019-2030)
4.2.1 Global Prescription & Rx Sunglass Revenue by Type (2019-2024)
4.2.2 Global Prescription & Rx Sunglass Revenue by Type (2025-2030)
4.2.3 Global Prescription & Rx Sunglass Revenue Market Share by Type (2019-2030)
4.3 Global Prescription & Rx Sunglass Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prescription & Rx Sunglass Sales by Application (2019-2030)
5.1.1 Global Prescription & Rx Sunglass Sales by Application (2019-2024)
5.1.2 Global Prescription & Rx Sunglass Sales by Application (2025-2030)
5.1.3 Global Prescription & Rx Sunglass Sales Market Share by Application (2019-2030)
5.2 Global Prescription & Rx Sunglass Revenue by Application (2019-2030)
5.2.1 Global Prescription & Rx Sunglass Revenue by Application (2019-2024)
5.2.2 Global Prescription & Rx Sunglass Revenue by Application (2025-2030)
5.2.3 Global Prescription & Rx Sunglass Revenue Market Share by Application (2019-2030)
5.3 Global Prescription & Rx Sunglass Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Luxottica (Italy)
6.1.1 Luxottica (Italy) Corporation Information
6.1.2 Luxottica (Italy) Description and Business Overview
6.1.3 Luxottica (Italy) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Luxottica (Italy) Prescription & Rx Sunglass Product Portfolio
6.1.5 Luxottica (Italy) Recent Developments/Updates
6.2 Safilo (France)
6.2.1 Safilo (France) Corporation Information
6.2.2 Safilo (France) Description and Business Overview
6.2.3 Safilo (France) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Safilo (France) Prescription & Rx Sunglass Product Portfolio
6.2.5 Safilo (France) Recent Developments/Updates
6.3 Charmant (US)
6.3.1 Charmant (US) Corporation Information
6.3.2 Charmant (US) Description and Business Overview
6.3.3 Charmant (US) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Charmant (US) Prescription & Rx Sunglass Product Portfolio
6.3.5 Charmant (US) Recent Developments/Updates
6.4 Marchon (US)
6.4.1 Marchon (US) Corporation Information
6.4.2 Marchon (US) Description and Business Overview
6.4.3 Marchon (US) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Marchon (US) Prescription & Rx Sunglass Product Portfolio
6.4.5 Marchon (US) Recent Developments/Updates
6.5 Fielmann (Germany)
6.5.1 Fielmann (Germany) Corporation Information
6.5.2 Fielmann (Germany) Description and Business Overview
6.5.3 Fielmann (Germany) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Fielmann (Germany) Prescription & Rx Sunglass Product Portfolio
6.5.5 Fielmann (Germany) Recent Developments/Updates
6.6 De Rigo (Italy)
6.6.1 De Rigo (Italy) Corporation Information
6.6.2 De Rigo (Italy) Description and Business Overview
6.6.3 De Rigo (Italy) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.6.4 De Rigo (Italy) Prescription & Rx Sunglass Product Portfolio
6.6.5 De Rigo (Italy) Recent Developments/Updates
6.7 Bausch & Lomb (US)
6.6.1 Bausch & Lomb (US) Corporation Information
6.6.2 Bausch & Lomb (US) Description and Business Overview
6.6.3 Bausch & Lomb (US) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bausch & Lomb (US) Prescription & Rx Sunglass Product Portfolio
6.7.5 Bausch & Lomb (US) Recent Developments/Updates
6.8 Carl Zeiss (Germany)
6.8.1 Carl Zeiss (Germany) Corporation Information
6.8.2 Carl Zeiss (Germany) Description and Business Overview
6.8.3 Carl Zeiss (Germany) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Carl Zeiss (Germany) Prescription & Rx Sunglass Product Portfolio
6.8.5 Carl Zeiss (Germany) Recent Developments/Updates
6.9 Essilor (France)
6.9.1 Essilor (France) Corporation Information
6.9.2 Essilor (France) Description and Business Overview
6.9.3 Essilor (France) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Essilor (France) Prescription & Rx Sunglass Product Portfolio
6.9.5 Essilor (France) Recent Developments/Updates
6.10 Rodenstock (Germany)
6.10.1 Rodenstock (Germany) Corporation Information
6.10.2 Rodenstock (Germany) Description and Business Overview
6.10.3 Rodenstock (Germany) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Rodenstock (Germany) Prescription & Rx Sunglass Product Portfolio
6.10.5 Rodenstock (Germany) Recent Developments/Updates
6.11 Hoya Corporation (Japan)
6.11.1 Hoya Corporation (Japan) Corporation Information
6.11.2 Hoya Corporation (Japan) Prescription & Rx Sunglass Description and Business Overview
6.11.3 Hoya Corporation (Japan) Prescription & Rx Sunglass Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hoya Corporation (Japan) Prescription & Rx Sunglass Product Portfolio
6.11.5 Hoya Corporation (Japan) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prescription & Rx Sunglass Industry Chain Analysis
7.2 Prescription & Rx Sunglass Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prescription & Rx Sunglass Production Mode & Process
7.4 Prescription & Rx Sunglass Sales and Marketing
7.4.1 Prescription & Rx Sunglass Sales Channels
7.4.2 Prescription & Rx Sunglass Distributors
7.5 Prescription & Rx Sunglass Customers
8 Prescription & Rx Sunglass Market Dynamics
8.1 Prescription & Rx Sunglass Industry Trends
8.2 Prescription & Rx Sunglass Market Drivers
8.3 Prescription & Rx Sunglass Market Challenges
8.4 Prescription & Rx Sunglass Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
